Clinical Trials Directory

Trials / Conditions / ALK Positive

ALK Positive

6 registered clinical trials studyying ALK Positive — 1 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Multicenter Real-world Clinical Study on the Efficacy and Safety of Ensartinib As Neoadjuvant Treatment for
NCT06736561
Harbin Medical University—
Active Not RecruitingStudy Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC
NCT06569420
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.Phase 3
UnknownEnsatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer
NCT05132218
Peking University Cancer Hospital & Institute—
Active Not RecruitingCeritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-I
NCT02321501
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingCrizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery
NCT02201992
ECOG-ACRIN Cancer Research GroupPhase 3
CompletedCeritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or
NCT02227940
Roswell Park Cancer InstitutePhase 1